First Horizon Corporation’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$159K Buy
412
+71
+21% +$26.3K 0.01% 462
2026
Q1
$99.8K Sell
341
-364
-52% -$120K ﹤0.01% 493
2025
Q4
$247K Buy
705
+265
+60% +$89.6K 0.01% 383
2025
Q3
$142K Buy
+440
New +$137K 0.01% 442
2021
Q2
$53K Sell
140
-2,455
-95% -$938K ﹤0.01% 372
2021
Q1
$931K Sell
2,595
-25
-1% -$8.04K 0.09% 148
2020
Q4
$841K Hold
2,620
0.08% 149
2020
Q3
$703K Buy
+2,620
New +$705K 0.07% 145
2013
Q2
$6K Buy
+78
New +$5.84K ﹤0.01% 473

Other funds holding ELV

First Horizon Corporation's ELV Position: Q2 2026 in Review

First Horizon Corporation increased its Elevance Health (ELV) stake by 21% in Q2 2026, buying an estimated $26.3K and bringing the position to 412 shares worth $159K. The position accounts for 0.01% of the portfolio, ranked #462.

First Horizon Corporation first reported a position in ELV in Q2 2013 and has held it in 9 quarters since. The position peaked at $931K in Q1 2021. 685 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • First Horizon Corporation held 412 shares of Elevance Health worth $159K as of Q2 2026.
  • First Horizon Corporation bought 71 Elevance Health shares in Q2 2026, an estimated $26.3K.
  • Elevance Health made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #462 holding.
  • First Horizon Corporation first reported a position in Elevance Health in Q2 2013 and has held it in 9 quarters since.
  • First Horizon Corporation's Elevance Health position peaked at $931K in Q1 2021.
  • 685 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.